Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results And Highlights For First Quarter 2014
5/6/2014 7:01:30 AM
CARLSBAD, Calif., May 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013. Isis' first quarter 2014 pro forma NOL was higher than the same period last year primarily due to variations in the timing of milestone payments from its partners and the planned increase in operating expenses associated with the Company's late-stage clinical programs.
Help employers find you! Check out all the jobs and post your resume.
comments powered by